AlzeCure's Abstract on Pain Project TrkA-NAM Accepted for Presentation at IASP 2022

STOCKHOLM, SWEDEN / ACCESSWIRE / June 1, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the …